<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the adult with acute diarrhea in resource-limited settings</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the adult with acute diarrhea in resource-limited settings</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the adult with acute diarrhea in resource-limited settings</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Regina LaRocque, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark Pietroni, MA, FRCP, FFPH, DTM&amp;H</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mohammod Jobayer Chisti, MBBS, MMed, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1169885057"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Diarrheal diseases are one of the leading causes of death globally [<a href="#rid1">1,2</a>]. Most cases of diarrhea are associated with contaminated food and water sources, and more than two billion people globally have no access to basic sanitation [<a href="#rid3">3</a>].</p><p>The World Health Organization (WHO) provides guidelines for the management of diarrheal illness in resource-limited countries in "The Treatment of Diarrhea: A Manual for Physicians and Other Senior Health Workers" [<a href="#rid4">4</a>]. Specific WHO guidelines for the management of epidemic shigellosis [<a href="#rid5">5</a>] and cholera [<a href="#rid6">6,7</a>] are also available. The recommendations in this topic are consistent with those guidelines. </p><p>This topic reviews the clinical assessment, treatment, and prevention of acute diarrhea, including watery diarrhea and dysentery, in adults in resource-limited countries. </p><p>The clinical assessment and management of children with acute diarrhea in resource-limited countries and of individuals with diarrhea in resource-rich settings are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/z/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings"</a> and  <a class="medical medical_review" href="/z/d/html/5877.html" rel="external">"Overview of the causes of chronic diarrhea in children in resource-abundant settings"</a>.)</p><p class="headingAnchor" id="H77501562"><span class="h1">CLASSIFICATION OF DIARRHEA</span><span class="headingEndMark"> — </span>Diarrhea is defined as the passage of loose or watery stools, typically at least three times in a 24-hour period [<a href="#rid8">8</a>]. Acute diarrhea is defined as diarrhea of ≤14 days in duration, in contrast to persistent (&gt;14 days and ≤30 days) or chronic (&gt;30 days) diarrhea. Invasive diarrhea, or dysentery, is defined as diarrhea with visible blood, in contrast to watery diarrhea. Dysentery is commonly associated with fever and abdominal pain.</p><p class="headingAnchor" id="H1169885064"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H1169885166"><span class="h2">Worldwide incidence</span><span class="headingEndMark"> — </span>Diarrhea is an important cause of morbidity and mortality worldwide. The Global Burden of Disease Study found that in 2019, diarrhea contributed to over 1.5 million deaths around the world, and was a leading cause of morbidity and mortality in children younger than five years; diarrheal illness contributed to the loss of 45.5 million disability-adjusted life years and caused 10 percent of deaths in this age group [<a href="#rid2">2</a>]. Death rates from diarrhea have declined with improvements in sanitation and more widespread use of oral rehydration solution. Nevertheless, nearly seven billion cases of diarrheal disease occur worldwide each year [<a href="#rid9">9</a>].</p><p>Diarrheal illness occurs at a baseline frequency in resource-limited countries, superimposed with epidemic cases of diarrhea, either dysentery or watery diarrhea. Epidemics are generally due to <em>Shigella dysenteriae </em>serotype 1 (Sd1) and <em>Vibrio cholerae</em>, but <em>Escherichia coli</em> O157:H7 can also be responsible for diarrheal outbreaks in resource-limited settings [<a href="#rid10">10</a>]. Major outbreaks due to Sd1 have occurred in Africa, South Asia, and Central America. In 1994, an explosive outbreak among Rwandan refugees in Zaire caused approximately 20,000 deaths during the first month alone [<a href="#rid11">11</a>]. Epidemics due to <em>V. cholerae</em> have occurred throughout Africa, Asia, the Middle East, South and Central America, and the Caribbean [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis", section on 'Epidemiology'</a> and  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H77501856"><span class="h2">Risk factors</span></p><p class="headingAnchor" id="H1169885173"><span class="h3">Crowding and poor sanitation</span><span class="headingEndMark"> — </span>Individuals in refugee camps and unplanned urban settlements, with limited access to water and sanitation facilities, are at particular risk of diarrheal epidemics. Contaminated food and water play an important role in such epidemics. Direct contact with an infected individual may also contribute to the spread of epidemic dysentery due to <em>S. dysenteriae</em>.</p><p class="headingAnchor" id="H1169885180"><span class="h3">HIV infection</span><span class="headingEndMark"> — </span>Human immunodeficiency virus (HIV) infection is prevalent in many of the resource-limited areas where acute diarrheal diseases occur, and diarrhea-related morbidity and mortality may be increased in these individuals. Several enteric bacteria, such as <em>Campylobacter</em>, <em>Salmonella</em>, <em>Shigella</em>, enteroaggregative <em>E. coli</em>, and <em>Vibrio</em> species, occur with increased frequency and/or severity in individuals with HIV/acquired immunodeficiency syndrome (AIDS) [<a href="#rid13">13,14</a>]. Coinfection with multiple pathogens may also occur. Nontyphoidal salmonellosis is a particular concern in individuals with HIV infection, who have a higher risk for recurrent or extraintestinal infection. (See  <a class="medical medical_review" href="/z/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>.) </p><p>Although individuals with HIV are susceptible to a broader variety of enteric pathogens, common causes of infectious diarrhea should be considered first among adults with acute diarrhea in resource-limited settings. (See  <a class="medical medical_review" href="/z/d/html/3728.html" rel="external">"Evaluation of the patient with HIV and diarrhea"</a>.) </p><p class="headingAnchor" id="H1169885073"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>A variety of bacteria, viruses, and parasites can cause acute diarrhea in resource-limited settings. </p><p>Information about the host, the type of diarrhea, and the clinical setting may be useful in indicating possible pathogens. However, a microbiologic diagnosis is not made in the majority of clinical cases in resource-limited countries and is not routinely required for clinical management. </p><p class="headingAnchor" id="H1169885231"><span class="h2">Epidemic diarrhea</span><span class="headingEndMark"> — </span><em>S. dysenteriae</em> and <em>V. cholerae</em> are the most common organisms associated with epidemic diarrhea. Epidemic refers to an increase, often sudden, in the number of cases of a disease above what is normally expected in that population in that area. Outbreak carries the same definition as epidemic, but it is often used for a more limited geographic area. </p><p>Four species of <em>Shigella</em> cause bloody diarrhea; they are distinguished serologically as <em>S. dysenteriae</em>, <em>S. flexneri</em>, <em>S. boydii</em>, and <em>S. sonnei</em> (see  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis"</a>). </p><p><em>S. dysenteriae</em> serotype 1 (Sd1) is uniquely responsible for epidemic dysentery. Important features accounting for the association between Sd1 and large, regional epidemics of dysentery include [<a href="#rid15">15-17</a>]:</p><p class="bulletIndent2"><span class="glyph">•</span>Sd1 produces a potent cytotoxin (Shiga toxin) that causes patchy destruction of the colonic epithelium</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The low infective dose (10 to 100 organisms) facilitates person-to-person spread of infection</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Illness due to Sd1 is more severe and more prolonged than illness due to other species of <em>Shigella</em></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sd1 resistance to antimicrobials is more common than in other species of <em>Shigella</em>; in addition, resistance to WHO recommended antibiotics is more common in Asian countries compared to Sub-Sahara Africa</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cholera is a secretory diarrheal disease caused by enterotoxin-producing strains of <em>V. cholerae</em>. More than 200 serogroups of <em>V. cholerae</em> have been identified to date, but historically, the O1 serogroup has caused the vast majority of disease. The O139 serogroup emerged as a cause of disease in 1992 [<a href="#rid18">18</a>], but has remained limited to a few countries in Asia. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Countries are said to be endemic for cholera if cholera cases have been reported in three of the previous five years. An outbreak of cholera occurs when a higher-than-expected number of cases are reported in a given area during a specific period of time. Outbreaks may occur in endemic or non-endemic areas and are more limited in scope compared to epidemics. In Africa, some countries appear to have cholera nearly every year, while other countries suffer from outbreaks every few years [<a href="#rid19">19-21</a>].</p><p></p><p>Rarely, enterohemorrhagic <em>E. coli</em> may cause epidemics of bloody diarrhea, similar to Sd1.</p><p class="headingAnchor" id="H1169885262"><span class="h2">Acute watery diarrhea</span><span class="headingEndMark"> — </span>A variety of pathogens can cause acute watery diarrhea in resource-limited settings  (<a class="graphic graphic_table graphicRef86525" href="/z/d/graphic/86525.html" rel="external">table 1</a>). In a non-epidemic situation, enterotoxigenic <em>E. coli</em> is the most common cause. In addition to causing epidemic disease, <em>V. cholerae</em> is endemic in approximately 50 countries in Asia, Africa, and Central and South America, where predictable seasonal outbreaks occur. Norovirus, <em>Campylobacter</em> species, nontyphoidal Salmonellae, <em>Aeromonas</em> species, and enteroaggregative <em>E. coli</em> are other pathogens that can cause acute watery diarrhea. </p><p class="headingAnchor" id="H1169885269"><span class="h2">Acute bloody diarrhea</span><span class="headingEndMark"> — </span>Worldwide, <em>Shigella</em> species, particularly <em>S. flexneri</em>, are the most important causes of acute bloody diarrhea. Other causes in resource-limited settings include Campylobacter jejuni, enteroinvasive and enterohemorrhagic <em>E. coli</em>, nontyphoidal <em>Salmonella</em> species, <em>Entamoeba histolytica</em>, and <em>Schistosoma mansoni</em>  (<a class="graphic graphic_table graphicRef86525" href="/z/d/graphic/86525.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H77501965"><span class="h1">CLINICAL FEATURES</span></p><p class="headingAnchor" id="H631066504"><span class="h2">Typical findings</span><span class="headingEndMark"> — </span>As above, diarrhea is the passage of loose stools, typically at least three times in a 24-hour period [<a href="#rid8">8</a>]. Watery diarrhea is characteristically nonbloody, whereas dysentery is defined as diarrhea with visible blood.</p><p>In an outbreak setting, these clinical features can be used to distinguish cholera (watery diarrhea) from epidemic dysentery due to <em>S. dysenteriae</em> serotype 1 (Sd1), as the distinction has therapeutic and public health implications  (<a class="graphic graphic_table graphicRef86522" href="/z/d/graphic/86522.html" rel="external">table 2</a>). (See <a class="local">'Antibiotic therapy'</a> below.)</p><p>A "rice-water" appearance of stool flecked with mucous is suggestive of cholera  (<a class="graphic graphic_picture graphicRef52564" href="/z/d/graphic/52564.html" rel="external">picture 1</a>) [<a href="#rid12">12</a>]. Furthermore, diarrhea caused by <em>V. cholerae</em> may present very suddenly with vomiting and abdominal cramping but not frank pain or tenesmus. Fever is uncommon in cholera. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p>In contrast, shigellosis is typically characterized by the frequent passage of small liquid stools that contain visible blood, with or without mucous [<a href="#rid22">22</a>]. Abdominal cramps and tenesmus are common, along with fever and anorexia. (See  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Clinical manifestations'</a>.)</p><p>However, within these two categories of diarrhea, the specific infectious causes cannot be determined based on signs or symptoms. The clinical illnesses caused by the various pathogens associated with watery diarrhea are typically indistinguishable. Similarly, Shigellosis cannot be distinguished reliably from other causes of bloody diarrhea on the basis of clinical features alone, nor can illness caused by Sd1 be distinguished with certainty from that caused by other <em>Shigella</em> species.</p><p class="headingAnchor" id="H10153248"><span class="h2">Complications of acute diarrheal diseases in adults</span><span class="headingEndMark"> — </span>The sequelae of severe volume depletion are the most important systemic complications of acute diarrheal disease in adults. Various clinical features can be helpful in determining the severity of hypovolemia, with sunken eyes, dry mouth and tongue, thirst, and decreased skin turgor seen with moderate hypovolemia and decreased consciousness/coma, inability to drink, and a weak pulse seen in more severe stages.</p><p>Hypovolemia and accompanying electrolyte imbalances are the most important complications of cholera. In contrast, severe volume depletion does not usually occur with <em>Shigella</em> infection; however, patients with <em>Shigella</em> infection often present with hyponatremia (potentially due to syndrome of inappropriate antidiuretic hormone secretion [SIADH]) [<a href="#rid23">23</a>].</p><p>Other systemic complications of diarrheal illness may occur in adults  (<a class="graphic graphic_table graphicRef86528" href="/z/d/graphic/86528.html" rel="external">table 3</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia (see  <a class="medical medical_review" href="/z/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemolytic-uremic syndrome (see  <a class="medical medical_review" href="/z/d/html/2718.html" rel="external">"Shigella infection: Epidemiology, clinical manifestations, and diagnosis", section on 'Hemolytic-uremic syndrome (HUS)'</a> and  <a class="medical medical_review" href="/z/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Complications'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Guillain-Barré syndrome (see  <a class="medical medical_review" href="/z/d/html/5137.html" rel="external">"Guillain-Barré syndrome in adults: Pathogenesis, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2715.html" rel="external">"Campylobacter infection: Clinical manifestations, diagnosis, and treatment", section on 'Guillain-Barré syndrome'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reactive arthritis (see  <a class="medical medical_review" href="/z/d/html/7794.html" rel="external">"Reactive arthritis", section on 'Clinical manifestations'</a>)</p><p></p><p>Serious complications may occur with <em>Shigella</em> infection, including sepsis, seizures, rectal prolapse, toxic megacolon, and the hemolytic-uremic syndrome. </p><p>Among individuals with HIV infection in resource-limited settings, bacteremia with non-typhoidal <em>Salmonella enterica</em> is a particular concern [<a href="#rid24">24</a>].</p><p class="headingAnchor" id="H77502176"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Acute diarrhea in adults in resource-limited settings is most frequently caused by an infectious agent. In addition to the pathogens above, diarrhea may also occur in the context of other systemic infections, such as influenza, HIV infection, dengue fever, and malaria. </p><p>Non-infectious etiologies of diarrhea are often missed and should be considered in patients with repeated episodes of self-limiting or acute diarrhea or chronic diarrhea. Such causes include inflammatory bowel disease and malabsorptive syndromes. (See  <a class="medical medical_review" href="/z/d/html/2591.html" rel="external">"Approach to the adult with chronic diarrhea in resource-abundant settings"</a>.)</p><p class="headingAnchor" id="H1169885082"><span class="h1">CLINICAL ASSESSMENT</span><span class="headingEndMark"> — </span>The initial evaluation of adults with acute diarrhea should include a careful history and physical examination in order to assess the type of diarrhea and the severity of hypovolemia. </p><p>Based on the appearance of the stool, diarrhea can be classified as watery or bloody. </p><p>The physical examination should focus on characterizing the degree of volume depletion  (<a class="graphic graphic_table graphicRef74796" href="/z/d/graphic/74796.html" rel="external">table 4</a>) [<a href="#rid4">4</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Early hypovolemia – Signs and symptoms may be absent; WHO terms this 'no dehydration'</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate hypovolemia – Thirst, restless or irritable behavior, decreased skin turgor, sunken eyes; WHO terms this 'some dehydration' </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe hypovolemia – Diminished consciousness, lack of urine output, cool moist extremities, rapid and feeble pulse, low or undetectable blood pressure, peripheral cyanosis; WHO terms this 'severe dehydration'</p><p></p><p>Laboratory studies are not typically needed. However, when available, certain diagnostic tests can help to identify the microbial etiology, which is especially useful in an epidemic situation. </p><p class="bulletIndent1"><span class="glyph">●</span>Routine microscopy of fresh stool is inexpensive and can identify the presence of numerous fecal leukocytes with any number of red blood cells, suggesting an invasive bacterial infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Microscopic evidence of <em>Entamoeba trophozoites</em> containing high counts of red blood cells provides sufficient basis for treating for amoebic dysentery instead of shigellosis  (<a class="graphic graphic_picture graphicRef57615" href="/z/d/graphic/57615.html" rel="external">picture 2</a>). Notably, finding cysts or trophozoites without red blood cells in a bloody stool does not indicate that <em>Entamoeba</em> is the cause of illness, since asymptomatic infection is frequent among healthy persons in resource-limited countries. (See  <a class="medical medical_review" href="/z/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cholera can be diagnosed using dark-field microscopy, in which motile Vibrios appear as "shooting stars," or by using a commercially available rapid dipstick.</p><p></p><p>Serum electrolyte and glucose testing is not routinely required for the treatment of an adult patient with an uncomplicated case of acute watery diarrhea. Testing may be considered in patients with ileus, confusion, or seizure, or in those with no urine output in response to fluid replacement. </p><p class="headingAnchor" id="H1169885090"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Treatment of adults with acute diarrhea consists of correcting fluid and electrolyte losses and administering appropriate nutrition. Antibiotic therapy is warranted in some circumstances, as outlined below. </p><p class="headingAnchor" id="H1169885319"><span class="h2">Rehydration</span><span class="headingEndMark"> — </span>Fluid management, including the type and quantity of fluids to administer, in an adult patient with diarrhea depends on the level of volume depletion  (<a class="graphic graphic_algorithm graphicRef86529" href="/z/d/graphic/86529.html" rel="external">algorithm 1</a>) [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H77502056"><span class="h3">None to moderate hypovolemia</span><span class="headingEndMark"> — </span>In the vast majority of cases, volume depletion from acute diarrhea of any etiology, except when it is severe, can be effectively treated with oral rehydration salts (ORS)  (<a class="graphic graphic_algorithm graphicRef86529" href="/z/d/graphic/86529.html" rel="external">algorithm 1</a>) [<a href="#rid26">26</a>]. An improved, reduced osmolarity ORS solution, containing 75 mEq/L of sodium and 75 mmol/L of glucose  (<a class="graphic graphic_table graphicRef86526" href="/z/d/graphic/86526.html" rel="external">table 5</a>), is officially recommended by the World Health Organization (WHO) and The United Nations Children’s Fund (UNICEF). This reduced osmolarity solution reduces the need for supplemental IV fluid therapy by 33 percent compared with the previous standard WHO ORS solution [<a href="#rid27">27,28</a>]. (See  <a class="medical medical_review" href="/z/d/html/6129.html" rel="external">"Oral rehydration therapy"</a>.)</p><p>The use of <a class="drug drug_general" data-topicid="8956" href="/z/d/drug information/8956.html" rel="external">glucose polymers</a> (primarily rice, but also wheat, sorghum, or maize) in ORS has been shown to decrease mean 24-hour stool output in adults with cholera when compared to the traditional, high osmolarity ORS [<a href="#rid29">29,30</a>]. However, the preparation of such polymer-based ORS is more tedious than that of traditional ORS, and further data are needed to assess its efficacy compared with the reduced osmolarity ORS solution. </p><p class="headingAnchor" id="H77502070"><span class="h3">Severe hypovolemia</span><span class="headingEndMark"> — </span>Adults with severe hypovolemia should receive intravenous fluids  (<a class="graphic graphic_algorithm graphicRef86529" href="/z/d/graphic/86529.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef62757" href="/z/d/graphic/62757.html" rel="external">table 6</a>) [<a href="#rid4">4</a>]. Preferred solutions include Ringer's lactate (with or without with 5 percent dextrose) or Cholera <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> ("Dhaka solution") [<a href="#rid31">31</a>]. Normal saline may be used but is less preferable because it does not contain potassium to replace losses nor a base to correct acidosis.</p><p class="headingAnchor" id="H1169885312"><span class="h2">Antibiotic therapy</span></p><p class="headingAnchor" id="H77502155"><span class="h3">Watery diarrhea</span><span class="headingEndMark"> — </span>Antimicrobial therapy is not typically indicated for the treatment of acute watery diarrhea in adults in resource-limited settings, as most cases resolve spontaneously. </p><p>An important exception is the treatment of severe cholera in outbreak settings, for which antibiotics can decrease the duration of illness and the volume of fluid losses, thus simplifying patient management during a complex emergency [<a href="#rid12">12</a>]. Reports of resistance in <em>V. cholerae</em> are increasing; data on local susceptibility should therefore be used to guide treatment choices. Antibiotic treatment of cholera is discussed in detail elsewhere  (<a class="graphic graphic_table graphicRef71548" href="/z/d/graphic/71548.html" rel="external">table 7</a>). (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H77502169"><span class="h3">Dysentery</span><span class="headingEndMark"> — </span>In contrast to the treatment of watery diarrhea, adults with bloody diarrhea should be treated promptly with an antimicrobial that is effective against <em>Shigella </em> (<a class="graphic graphic_table graphicRef68382" href="/z/d/graphic/68382.html" rel="external">table 8</a>)<em> </em>[<a href="#rid4">4</a>]. Patients who do not respond after 48 hours or deteriorate within 24 to 48 hours can be switched to a different antimicrobial agent. If there is still no response, treatment for amebic dysentery due to <em>E. histolytica</em> can be given. Although initial empiric treatment for amebic dysentery is not routinely warranted, it should be given at any point if trophozoites are visualized on stool microscopy. Treatment for amebic dysentery usually entails <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> (500 to 750 mg orally three times daily for 7 to 10 days) followed by an intraluminal agent; this is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5727.html" rel="external">"Intestinal Entamoeba histolytica amebiasis"</a>.)</p><p>Treatment should be particularly targeted at those with higher risks of complications, including individuals with AIDS and older adults. The choice of antimicrobial should be based on recent susceptibility data from <em>Shigella</em> strains isolated in the area. If no such data are available, <a class="drug drug_general" data-topicid="9267" href="/z/d/drug information/9267.html" rel="external">ciprofloxacin</a> or <a class="drug drug_general" data-topicid="9041" href="/z/d/drug information/9041.html" rel="external">azithromycin</a> are reasonable first-line antibiotics, although clinicians should be aware that failure due to resistance is possible and second-line drugs may be required. </p><p>In several trials of patients with dysentery, antibiotics reduced the duration of diarrhea and fever in infections caused by <em>Shigella</em>, which is the most common cause of dysentery in resource-limited settings and can otherwise be associated with severe complications [<a href="#rid5">5,32</a>]. Antibiotic therapy for shigellosis is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">"Shigella infection: Treatment and prevention in adults", section on 'Antibiotic treatment'</a>.)</p><p class="headingAnchor" id="H1169885338"><span class="h3">Antimicrobial resistance</span><span class="headingEndMark"> — </span>Antimicrobial resistance in enteric pathogens in resource-limited settings is increasingly common [<a href="#rid33">33,34</a>] and is, in part, due to the misuse and overuse of antibiotics in the treatment of diarrheal diseases. Multidrug resistance has been identified in nontyphoidal <em>Salmonella</em>, <em>Shigella</em> spp, and <em>V. cholerae</em> [<a href="#rid35">35-39</a>]; resistance complicates the antibiotic treatment of severely ill patients and the management of diarrheal outbreaks. One study of diarrheal stool samples in rural western Kenya determined that most persons had been treated with an antimicrobial to which their isolate was resistant [<a href="#rid40">40</a>]. When possible, the selection of antimicrobial treatment for acute diarrheal diseases should therefore be based on recent susceptibility testing of strains from the area. Restriction of public retail availability of antimicrobial agents may also play a role in containing resistance. (See  <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">"Shigella infection: Treatment and prevention in adults", section on 'Antibiotic resistance'</a> and  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H1169885345"><span class="h2">Dietary recommendations</span><span class="headingEndMark"> — </span>The continuous provision of nutritious food is important for all patients with diarrhea. Small meals can be provided frequently, as soon as the patient is able to tolerate.</p><p class="headingAnchor" id="H1169885106"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Acute diarrheal diseases can be prevented with a variety of measures focused on preventing the spread of organisms from person to person and within the community [<a href="#rid41">41,42</a>]. These include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hand washing with soap</p><p class="bulletIndent1"><span class="glyph">●</span>Ensuring the availability of safe drinking water</p><p class="bulletIndent1"><span class="glyph">●</span>Appropriate disposal of human waste</p><p class="bulletIndent1"><span class="glyph">●</span>Breastfeeding of infants and young children</p><p class="bulletIndent1"><span class="glyph">●</span>Safe handling and processing of food</p><p class="bulletIndent1"><span class="glyph">●</span>Control of flies (particularly for Sd1)</p><p></p><p>Two killed whole-cell oral cholera vaccines are internationally licensed and prequalified by the World Health Organization (WHO). A WHO global cholera vaccine stockpile of the lower cost bivalent vaccine was created in 2013 and has led to increasing use of killed oral cholera vaccines globally; the monovalent vaccine has been used primarily in travelers from resource-rich countries. (See  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p>Candidate vaccines for shigellosis are undergoing testing.</p><p class="headingAnchor" id="H2517501074"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109942.html" rel="external">"Society guideline links: Acute diarrhea in adults"</a>.)</p><p class="headingAnchor" id="H1169885113"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> − Diarrheal illness in resource-limited settings is extremely common, but incidence rates for adults have not been systematically calculated. Cases of diarrhea can occur as baseline endemic disease or in the setting of epidemics. Poor sanitation is a major risk factor for the prevalence of diarrhea in both endemic and epidemic forms. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> − Multiple pathogens can cause watery and bloody diarrhea (dysentery)  (<a class="graphic graphic_table graphicRef86525" href="/z/d/graphic/86525.html" rel="external">table 1</a>). <em>Shigella dysenteriae</em> serotype 1 and <em>Vibrio cholerae</em> are the most important causes of diarrheal epidemics, and certain clinical features can distinguish between the two  (<a class="graphic graphic_table graphicRef86522" href="/z/d/graphic/86522.html" rel="external">table 2</a>). (See <a class="local">'Microbiology'</a> above and <a class="local">'Clinical features'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> − Severe volume depletion is the most important complication of acute diarrheal illness in adults. However, several other systemic complications can occur, including bacteremia, hemolytic-uremic syndrome, Guillain-Barré syndrome, and reactive arthritis. (See <a class="local">'Complications of acute diarrheal diseases in adults'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical assessment</strong> − The clinical assessment of the adult patient with acute diarrhea should focus on characterizing the type of diarrhea (watery versus bloody) and the degree of volume depletion. A microbiologic diagnosis is not needed in the majority of clinical cases of adults with diarrheal illness in resource-limited countries. (See <a class="local">'Clinical assessment'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rehydration</strong> − Adequate fluid and electrolyte replacement and maintenance are essential to the management of all diarrheal illnesses  (<a class="graphic graphic_algorithm graphicRef86529" href="/z/d/graphic/86529.html" rel="external">algorithm 1</a> and <a class="graphic graphic_table graphicRef86526" href="/z/d/graphic/86526.html" rel="external">table 5</a>). (See <a class="local">'Rehydration'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of antibiotic therapy </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Watery diarrhea</strong> − For most patients with acute watery diarrhea, we suggest not routinely administering empiric antimicrobial therapy (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). One exception is in the epidemic setting, in which antibiotic therapy against cholera can decrease the duration of illness and the volume of fluid losses and thus simplify patient management during a complex emergency  (<a class="graphic graphic_table graphicRef71548" href="/z/d/graphic/71548.html" rel="external">table 7</a>). (See <a class="local">'Watery diarrhea'</a> above and  <a class="medical medical_review" href="/z/d/html/2704.html" rel="external">"Cholera: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Bloody diarrhea</strong> − For adults with bloody diarrhea, we suggest prompt empiric antibiotic treatment (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). An antimicrobial that is effective against <em>Shigella</em> should be used  (<a class="graphic graphic_table graphicRef68382" href="/z/d/graphic/68382.html" rel="external">table 8</a>). (See <a class="local">'Dysentery'</a> above and  <a class="medical medical_review" href="/z/d/html/2701.html" rel="external">"Shigella infection: Treatment and prevention in adults", section on 'Antibiotic treatment'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018; 18:1211.</a></li><li><a class="nounderline abstract_t">GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396:1204.</a></li><li class="breakAll">World Health Organization. Progress on Drinking Water, Sanitation and Hygiene: 2017 Update and SDG Baselines. https://www.unicef.org/publications/files/Progress_on_Drinking_Water_Sanitation_and_Hygiene_2017.pdf (Accessed on December 04, 2018).</li><li class="breakAll">World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. -- 4th revision. Geneva, Switzerland: World Health Organization, 2005.</li><li class="breakAll">Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. Geneva, Switzerland: World Health Organization, 2005.</li><li class="breakAll">United States Centers for Disease Control and Prevention. Cholera - Vibrio cholerae infection. https://www.cdc.gov/cholera/treatment/index.html (Accessed on December 04, 2018).</li><li class="breakAll">World Health Organization. Cholera. http://www.who.int/cholera/en/ (Accessed on December 04, 2018).</li><li><a class="nounderline abstract_t">Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32:331.</a></li><li class="breakAll">IHME. Diarrheal diseases — Level 3 cause. https://www.healthdata.org/results/gbd_summaries/2019/diarrheal-diseases-level-3-cause (Accessed on December 16, 2022).</li><li><a class="nounderline abstract_t">Effler E, Isaäcson M, Arntzen L, et al. Factors contributing to the emergence of Escherichia coli O157 in Africa. Emerg Infect Dis 2001; 7:812.</a></li><li><a class="nounderline abstract_t">Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group. Lancet 1995; 345:339.</a></li><li><a class="nounderline abstract_t">Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet 2012; 379:2466.</a></li><li><a class="nounderline abstract_t">Angulo FJ, Swerdlow DL. Bacterial enteric infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21 Suppl 1:S84.</a></li><li><a class="nounderline abstract_t">Wanke CA, Mayer H, Weber R, et al. Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis 1998; 178:185.</a></li><li><a class="nounderline abstract_t">Niyogi SK. Shigellosis. J Microbiol 2005; 43:133.</a></li><li><a class="nounderline abstract_t">Ndlovu N, Tarupiwa A, Mudzori JT. Antimicrobial resistence of Shigella species isolated during 2004 and 2005 from selected sites in Zimbabwe. Cent Afr J Med 2006; 52:93.</a></li><li><a class="nounderline abstract_t">Talukder KA, Khajanchi BK, Islam MA, et al. The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal. Epidemiol Infect 2006; 134:1249.</a></li><li><a class="nounderline abstract_t">Ramamurthy T, Garg S, Sharma R, et al. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 1993; 341:703.</a></li><li class="breakAll">World Health Organization. Definitions: emergencies. http://www.who.int/hac/about/definitions/en/ (Accessed on December 04, 2018).</li><li class="breakAll">United States Centers for Disease Control and Prevention. Principles of Epidemiology in Public Health Practice, Third Edition: An Introduction to Applied Epidemiology and Biostatistics, Lesson 1: Introduction to Epidemiology, Section 11: Epidemic Disease Occurrence. https://www.cdc.gov/ophss/csels/dsepd/ss1978/lesson1/section11.html (Accessed on December 04, 2018).</li><li class="breakAll">Stop Cholera. Frequently Asked Questions. https://www.stopcholera.org/content/frequently-asked-questions#burden (Accessed on December 04, 2018).</li><li><a class="nounderline abstract_t">Stoll BJ, Glass RI, Huq MI, et al. Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh. J Infect Dis 1982; 146:177.</a></li><li><a class="nounderline abstract_t">Shahrin L, Chisti MJ, Huq S, et al. Clinical Manifestations of Hyponatremia and Hypernatremia in Under-Five Diarrheal Children in a Diarrhea Hospital. J Trop Pediatr 2016; 62:206.</a></li><li><a class="nounderline abstract_t">Gordon MA. Salmonella infections in immunocompromised adults. J Infect 2008; 56:413.</a></li><li class="breakAll">World Health Organization. First steps for managing an oubreak of acute diarrhea. Geneva, Switzerland: World Health Organization, 2004.</li><li><a class="nounderline abstract_t">Victora CG, Bryce J, Fontaine O, Monasch R. Reducing deaths from diarrhoea through oral rehydration therapy. Bull World Health Organ 2000; 78:1246.</a></li><li><a class="nounderline abstract_t">Hahn S, Kim S, Garner P. Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children. Cochrane Database Syst Rev 2002; :CD002847.</a></li><li><a class="nounderline abstract_t">Alam NH, Majumder RN, Fuchs GJ. Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group. Lancet 1999; 354:296.</a></li><li><a class="nounderline abstract_t">Gregorio GV, Gonzales ML, Dans LF, Martinez EG. Polymer-based oral rehydration solution for treating acute watery diarrhoea. Cochrane Database Syst Rev 2016; 12:CD006519.</a></li><li><a class="nounderline abstract_t">Ramakrishna BS, Venkataraman S, Srinivasan P, et al. Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med 2000; 342:308.</a></li><li><a class="nounderline abstract_t">Alam NH, Ashraf H, Sarker SA, et al. Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults. Digestion 2008; 78:24.</a></li><li><a class="nounderline abstract_t">Christopher PR, David KV, John SM, Sankarapandian V. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2010; :CD006784.</a></li><li><a class="nounderline abstract_t">Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005; 5:481.</a></li><li><a class="nounderline abstract_t">Kariuki S, Hart CA. Global aspects of antimicrobial-resistant enteric bacteria. Curr Opin Infect Dis 2001; 14:579.</a></li><li><a class="nounderline abstract_t">Mandomando I, Espasa M, Vallès X, et al. Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique. J Antimicrob Chemother 2007; 60:662.</a></li><li><a class="nounderline abstract_t">Taneja N, Mohan B, Khurana S, Sharma M. Antimicrobial resistance in selected bacterial enteropathogens in north India. Indian J Med Res 2004; 120:39.</a></li><li><a class="nounderline abstract_t">Rahman M, Shoma S, Rashid H, et al. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr 2007; 25:158.</a></li><li><a class="nounderline abstract_t">Tjaniadi P, Lesmana M, Subekti D, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003; 68:666.</a></li><li class="breakAll">Surveillance Update. ICDDR,B:Health and Science Bulletin 2010; 8:19.</li><li><a class="nounderline abstract_t">Brooks JT, Ochieng JB, Kumar L, et al. Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis 2006; 43:393.</a></li><li><a class="nounderline abstract_t">Fewtrell L, Kaufmann RB, Kay D, et al. Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis. Lancet Infect Dis 2005; 5:42.</a></li><li><a class="nounderline abstract_t">Ejemot RI, Ehiri JE, Meremikwu MM, Critchley JA. Hand washing for preventing diarrhoea. Cochrane Database Syst Rev 2008; :CD004265.</a></li></ol></div><div id="topicVersionRevision">Topic 13954 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30243583" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33069326" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11170940" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Practice guidelines for the management of infectious diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11170940" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Practice guidelines for the management of infectious diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11747693" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Factors contributing to the emergence of Escherichia coli O157 in Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7646638" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Public health impact of Rwandan refugee crisis: what happened in Goma, Zaire, in July, 1994? Goma Epidemiology Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22748592" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8547518" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Bacterial enteric infections in persons infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9652439" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15880088" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Shigellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20353132" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Antimicrobial resistence of Shigella species isolated during 2004 and 2005 from selected sites in Zimbabwe.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16684401" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8095620" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8095620" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8095620" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8095620" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7108270" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Epidemiologic and clinical features of patients infected with Shigella who attended a diarrheal disease hospital in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26851435" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Clinical Manifestations of Hyponatremia and Hypernatremia in Under-Five Diarrheal Children in a Diarrhea Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18474400" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Salmonella infections in immunocompromised adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18474400" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Salmonella infections in immunocompromised adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11100619" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Reducing deaths from diarrhoea through oral rehydration therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11869639" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Reduced osmolarity oral rehydration solution for treating dehydration caused by acute diarrhoea in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10440307" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27959472" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Polymer-based oral rehydration solution for treating acute watery diarrhoea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655529" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Amylase-resistant starch plus oral rehydration solution for cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18769066" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Efficacy of partially hydrolyzed guar gum-added oral rehydration solution in the treatment of severe cholera in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20687081" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Antibiotic therapy for Shigella dysentery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16048717" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Antimicrobial resistance in developing countries. Part I: recent trends and current status.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11964879" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Global aspects of antimicrobial-resistant enteric bacteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17626024" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15299231" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Antimicrobial resistance in selected bacterial enteropathogens in north India.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17985817" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12887025" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12887025" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16838225" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15620560" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18254044" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hand washing for preventing diarrhoea.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
